☆ 4.8 Editorial Material

Does clozapine treat antipsychotic-induced behavioural supersensitivity through glutamate modulation within the striatum?

MOLECULAR PSYCHIATRY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Psychiatry

Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis

Dan Siskind et al.

Summary: Treatment-resistant schizophrenia (TRS) is associated with high levels of functional impairment, healthcare usage and societal costs. A systematic review found that almost a quarter of individuals with first-episode psychosis or schizophrenia will develop TRS in the early stages of treatment, highlighting the need for improved access to clozapine and psychosocial supports.

BRITISH JOURNAL OF PSYCHIATRY (2022)

添加到收藏夹

Article Neurosciences

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients

Hana Hribkova et al.

Summary: This study investigated the cellular pathology and potential of antipsychotics in treating schizophrenia at the neuronal level. The findings suggest that neurons derived from schizophrenia patients show deficits in electrophysiological properties, synaptic function, and network activity, which can be restored by clozapine treatment in patients who respond to the drug. Additionally, clozapine treatment reverses gene expression dysregulation in neurons from clozapine-responsive patients. This study highlights the importance of K+ and Na+ channels and glutamatergic synaptic signaling in schizophrenia, and suggests that clozapine may act by normalizing perturbances in this signaling pathway.

FRONTIERS IN CELLULAR NEUROSCIENCE (2022)

添加到收藏夹

Review Psychiatry

Glutamatergic dysfunction in Schizophrenia

Andreas O. Kruse et al.

Summary: The NMDA-R hypofunction model suggests that brain glutamatergic abnormalities play a role in the etiology of schizophrenia. However, whether NMDA-R hypofunction is a significant component of the illness is still unclear. The glutamatergic model has heuristic value for guiding future research in schizophrenia.

TRANSLATIONAL PSYCHIATRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia

Silas A. Buck et al.

Summary: Dopamine and glutamate neurotransmission play important roles in the pathophysiology of schizophrenia. However, focusing solely on neurons that release dopamine or glutamate cannot fully explain the disease. Treatment strategies should target both dopamine and glutamate signaling, as they interact extensively. Additionally, neurons that co-release dopamine and glutamate may provide a missing link in our understanding of schizophrenia pathophysiology.

MOLECULAR PSYCHIATRY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia

Andrea de Bartolomeis et al.

PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Neurosciences

A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders

Jocelyn Wong et al.

Summary: This review examines the effectiveness of clozapine as an intervention for tardive dyskinesia and dystonia in patients with various psychiatric conditions. The results suggest that clozapine has overall effectiveness in treating TD for patients with a range of psychiatric conditions, but different psychiatric diagnoses may require different treatment protocols in terms of response time and dosage. However, most of the studies identified have inadequate qualities, highlighting the need for high-quality studies to provide clearer evidence.

PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Psychiatry

Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders

Sherry Kit Wa Chan et al.

Summary: Research on the long-term development and early predictors of treatment-resistant schizophrenia (TRS) and clozapine-resistant TRS (CR-TRS) in patients with first-episode schizophrenia-spectrum disorders (FES) found that factors such as younger age of onset, poorer social adjustment, longer illness duration, and higher antipsychotic dose were associated with the development of TRS. Patients with CR-TRS had poorer outcomes compared to non-CR-TRS patients, suggesting the importance of early intervention and clozapine initiation in improving patient outcomes.

SCHIZOPHRENIA BULLETIN (2021)

添加到收藏夹

Article Psychiatry

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia

Grant McQueen et al.

Summary: The study found that 12 weeks of clozapine treatment was associated with a longitudinal reduction in glutamate concentration in the caudate nucleus, but not in the ACC. The reduction in caudate glutamate concentration was positively correlated with percentage improvement in symptoms.

SCHIZOPHRENIA BULLETIN (2021)

添加到收藏夹

Review Psychiatry

Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms

Yutaro Shimomura et al.

Summary: Current guidelines and algorithms recommend increasing antipsychotic dose and switching to another antipsychotic, particularly clozapine, for treatment-resistant schizophrenia during the acute phase.

SCHIZOPHRENIA RESEARCH (2021)

添加到收藏夹

Article Psychiatry

Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats

Makoto Kimura et al.

Summary: Repeated electroconvulsive shock (ES) can help rats with dopamine supersensitivity psychosis (DSP) to recover from dopamine supersensitivity states, improving symptoms in the DSP model rats.

SCHIZOPHRENIA RESEARCH (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Accumbens D2-MSN hyperactivity drives antipsychotic-induced behavioral supersensitivity

Anna Kruyer et al.

Summary: Antipsychotic-induced dopamine supersensitivity is a problematic consequence of long-term antipsychotic treatment, characterized by motor abnormalities, refractory symptoms, and rebound psychosis. This phenomenon is associated with long-lasting synaptic plasticity and hyperexcitability in a subpopulation of D2 receptor-expressing neurons, leading to behavioral endophenotypes of treatment resistance and substance use disorder. Chemogenetic restoration of inhibitory postsynaptic currents may offer a novel therapeutic direction for preventing antipsychotic-induced supersensitivity.

MOLECULAR PSYCHIATRY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter

Davide Amato et al.

MOLECULAR PSYCHIATRY (2020)

添加到收藏夹

Article Psychology, Clinical

Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study

Jose M. Rubio et al.

PSYCHOLOGICAL MEDICINE (2020)

添加到收藏夹

Review Psychiatry

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

Steven G. Potkin et al.

NPJ SCHIZOPHRENIA (2020)

添加到收藏夹

Review Clinical Neurology

Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review

Parnian Pardis et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2019)

添加到收藏夹

Article Neurosciences

Clozapine increased c-Fos protein expression in several brain subregions of socially isolated rats

Andrijana Stanisavljevic et al.

BRAIN RESEARCH BULLETIN (2019)

添加到收藏夹

Article Psychiatry

Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment

Amir Krivoy et al.

SCHIZOPHRENIA RESEARCH (2018)

添加到收藏夹

Article Psychology, Clinical

Relapse After Antipsychotic Discontinuation in Schizophrenia as a Withdrawal Phenomenon vs Illness Recurrence: A Post Hoc Analysis of a Randomized Placebo-Controlled Study

Robin Emsley et al.

JOURNAL OF CLINICAL PSYCHIATRY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia

Yusuke Nakata et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2017)

添加到收藏夹

Article Psychiatry

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

Guy Chouinard et al.

PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)

添加到收藏夹

Article Psychiatry

Nature of Glutamate Alterations in Schizophrenia A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

Kate Merritt et al.

JAMA PSYCHIATRY (2016)

添加到收藏夹

Article Clinical Neurology

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia

Meghan Elizabeth Goldstein et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)

添加到收藏夹

Letter Neurosciences

Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function

Arsime Demjaha et al.

BIOLOGICAL PSYCHIATRY (2014)

添加到收藏夹

Article Pharmacology & Pharmacy

Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes

Shunske Tanahashi et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

添加到收藏夹

Article Neurosciences

Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat

Maria Elena Bringas et al.

NEUROPHARMACOLOGY (2012)

添加到收藏夹

Review Neurosciences

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

Bita Moghaddam et al.

NEUROPSYCHOPHARMACOLOGY (2012)

添加到收藏夹

Review Psychiatry

Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse

J. Moncrieff

ACTA PSYCHIATRICA SCANDINAVICA (2006)

添加到收藏夹

Article Psychiatry

Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients

DC Javitt

CURRENT OPINION IN PSYCHIATRY (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine

M Melone et al.

MOLECULAR PSYCHIATRY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.